SPIREA
Spirea Ltd. operates as a healthcare technology company that has developed a smart polymer platform for the controlled delivery of drug combinations to maximise the clinical impact of medicines.
SPIREA
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2017-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.spirea.co.uk
Total Employee:
1+
Status:
Active
Total Funding:
2.4 M GBP
Similar Organizations
Aro Biotherapeutics
Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
ImmunOs Therapeutics
ImmunOs Therapeutics is a clinical-stage biotechnology company.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
KBP Biosciences
A multinational clinical stage biotechnology company.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Investors List
SyndicateRoom
SyndicateRoom investment in Venture Round - Spirea
O2h Ventures
O2h Ventures investment in Venture Round - Spirea
R42 Group
R42 Group investment in Venture Round - Spirea
Jonathan Milner
Jonathan Milner investment in Venture Round - Spirea
Cambridge Angels group
Cambridge Angels group investment in Venture Round - Spirea
ACF Investors
ACF Investors investment in Venture Round - Spirea
University of Cambridge Enterprise
University of Cambridge Enterprise investment in Venture Round - Spirea
O2h Ventures
O2h Ventures investment in Seed Round - Spirea
SyndicateRoom
SyndicateRoom investment in Seed Round - Spirea
Start Codon
Start Codon investment in Seed Round - Spirea
Official Site Inspections
http://www.spirea.co.uk
- Host name: 213.14.214.35.bc.googleusercontent.com
- IP address: 35.214.14.213
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Spirea"
Spirea – Elevating the Therapeutic Potential of …
At Spirea, we are revolutionising healthcare with our unique multivalent ELIVATE linker technology. Our mission is to enable next generation ADCs that address critical unmet needs in oncology and other diseases. ... [email protected] …See details»
Spirea welcomes Dr Bo Rode Hansen as Executive Director as the …
Cambridge, UK, 4th November 2024: Spirea Limited, a biopharmaceutical company developing a new generation of antibody drug conjugate (ADC) cancer therapeutics, based on its unique …See details»
Spirea - Crunchbase Company Profile & Funding
Spirea Ltd. may be growing as it has secured GBP 2.4 million in funding, which is a strong indicator of investor confidence and financial backing to support its operations and potential …See details»
Spirea Ltd. - Life-Sciences-Europe.com
Organisation › Details Spirea Ltd. https://www.spirea.co.uk. Spirea has developed an exciting and flexible new approach to building ADCs that allows more drug payload to be specifically …See details»
Spirea Overview | SignalHire Company Profile
Organization Website: spirea.co.uk : Social Links: Spirea industries Biotech: Headquarters Location: Cambridge, 1853 GB Cambridge, 1853 GB : Spirea Employees Size 1-10 …See details»
Spirea: Better treatment options for hard-to-treat cancers
5 days ago Spirea has successfully secured significant investments to advance its research and development. In 2020, they raised £2.4 million in a funding round co-led by Cambridge …See details»
SPIREA LIMITED overview - Find and update company information
GOV.UK Find and update company information Companies House does not verify the accuracy of the information filed (link opens a new window) ... People for SPIREA LIMITED (09817891) …See details»
Spirea - VentureRadar
Spirea Limited is a Cambridge-based company created to advance a new generation of antibody-targeted cancer treatments with significantly better efficacy and safety profiles. Spirea will use …See details»
Dr Myriam Ouberai shortlisted for Woman Entrepreneur of the …
Mar 8, 2024 Spirea’s CEO, Dr Myriam Ouberai, is proud and delighted, to have been shortlisted for Woman Entrepreneur of the Year at the Cancer Research Horizons – Innovation and …See details»
Spirea Ltd - Harrogate, United Kingdom - bionity.com
Jun 21, 2022 spirea.co.uk. Contact. Profile News. Contact. About Spirea. Spirea has developed an exciting and flexible new approach to building ADCs that allows more drug payload to be …See details»
SPIREA LIMITED Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for SPIREA LIMITED of HARROGATE. Get the latest business insights from Dun & Bradstreet.See details»
Spirea - LinkedIn
Spirea’s CEO, Dr Myriam Ouberai, is proud and delighted, to have been shortlisted for Woman Entrepreneur of the Year at the Cancer Research Horizons - Innovation and Entrepreneurship …See details»
Spirea Ltd receives pre-seed funding from the University of …
Dec 4, 2019 Spirea Ltd today announced that it is delighted to have received pre-seed funding from the University of Cambridge Enterprise Seed Funds. The funding will be used to further …See details»
Spirea Limited | Insights
Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Spirea - Company Profile - Tracxn
2 days ago Spirea - Developer of therapeutic solutions for cancer treatments. Raised a total funding of $2.93M over 5 rounds from 13 investors. Founded by Myriam Ouberai in the year …See details»
Spirea - Overview, News & Similar companies | ZoomInfo.com
Jul 13, 2020 Spirea Raises £2.4M ($3M) to Develop Antibody Drug Conjugates in Cancer CAMBRIDGE, England--(BUSINESS WIRE)--Spirea Limited, a Cambridge company created …See details»
NEWS - spirea.co.uk
Spirea granted UK patent on its high drug-to-antibody ratio ADC platform technology. Read More. Spirea raises £2.4M ($3M) to develop antibody drug conjugates in cancer. ...See details»
Spirea – Funding, Valuation, Investors, News
Essential stats, news, real-time insights on Spirea. Connect with decision makers, founders, investors. Explore valuation, funding rounds, reviews.See details»
Spirea - Start Codon
Spirea will use its revolutionary technology to build a pipeline of proprietary and partnered ADC therapeutics with enhanced therapeutic index. Spirea is a University of Cambridge spin out. …See details»
Category: News - spirea.co.uk
Spirea welcomes Dr Bo Rode Hansen as Executive Director as the company further strengthens its management and business capabilities. Cambridge, UK, 4th November 2024: Spirea …See details»